RNAZ
TRANSCODE THERA (RNAZ)
NASDAQ
$8.61+$0.05 (+0.58%)
Price as of Jul 13, 2026 5:47 PM EDT
  • $8.4M
    Market Cap
  • -6.04%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
KEPOS CAPITAL LP
28.94%
275,000
-25,000 (-9.09%)
Mar 31, 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP
2.19%
20,854
+20,854 (+100.00%)
Dec 31, 2022
GEODE CAPITAL MANAGEMENT, LLC
1.34%
12,740
+12,740 (+100.00%)
Mar 31, 2026
UBS GROUP AG
0.87%
8,295
+5,331 (+64.27%)
Mar 31, 2026
N/A
0.69%
6,545
+6,545 (+100.00%)
Mar 31, 2026
ACT CAPITAL MANAGEMENT, LLC
0.68%
6,500
0 (0.00%)
Sep 30, 2022
VANGUARD FIDUCIARY TRUST CO
0.31%
2,982
+2,982 (+100.00%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions10.2M (67.96%)
  • Mutual Funds3.7M (24.68%)
  • Insiders1.1M (7.36%)
  • Other0 (0.00%)

Insider Transactions

  • 7.36% (1.1M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
No data found

No data found